US 1025059A
· Joseph et al.
· 1912
[cited by applicant]
US 1611725A
· Degerth et al.
· 1926
[cited by applicant]
US 2087778A
· Nelin
· 1937
[cited by applicant]
US 2661150A
· Abbott, Jr.
· 1953
[cited by applicant]
US 2750107A
· More
· 1956
[cited by applicant]
US 2792172A
· Tait
· 1957
[cited by applicant]
US 3096283A
· Hein
· 1963
[cited by applicant]
US 3145713A
· Latham
· 1964
[cited by applicant]
US 3239136A
· Hein
· 1966
[cited by applicant]
US 3244362A
· Hein
· 1966
[cited by applicant]
US 3244363A
· Hein
· 1966
[cited by applicant]
US 3409213A
· Latham
· 1968
[cited by applicant]
US 3456875A
· Hein
· 1969
[cited by applicant]
US 3489145A
· Judson et al.
· 1970
[cited by applicant]
US 3565330A
· Allen
· 1971
[cited by applicant]
US 3655058A
· Novak
· 1972
[cited by applicant]
US 3737096A
· Jones et al.
· 1973
[cited by applicant]
US 3774840A
· Boatright
· 1973
[cited by applicant]
US 3987961A
· Sinn et al.
· 1976
[cited by applicant]
US 4007871A
· Jones et al.
· 1977
[cited by applicant]
US 4010894A
· Kellogg et al.
· 1977
[cited by applicant]
US 4014497A
· Spiewok et al.
· 1977
[cited by applicant]
US 4040965A
· Kohlheb
· 1977
[cited by applicant]
US 4056224A
· Lolachi
· 1977
[cited by applicant]
US 4082217A
· Westberg
· 1978
[cited by applicant]
US 4086925A
· Dodge
· 1978
[cited by applicant]
US 4140268A
· Lacour
· 1979
[cited by applicant]
US 4142670A
· Ishimaru et al.
· 1979
[cited by applicant]
US 4151844A
· Almond et al.
· 1979
[cited by applicant]
US 4197847A
· Djerassi
· 1980
[cited by applicant]
US 4285464A
· Latham
· 1981
[cited by applicant]
US 4300717A
· Latham
· 1981
[cited by applicant]
US 4303193A
· Latham
· 1981
[cited by applicant]
US 4321921A
· Laszczower
· 1982
[cited by applicant]
US 4387848A
· Kellogg et al.
· 1983
[cited by applicant]
US 4425114A
· Schoendorfer et al.
· 1984
[cited by applicant]
US 4430072A
· Kellogg et al.
· 1984
[cited by applicant]
US 4447221A
· Mulzet
· 1984
[cited by applicant]
US 4457747A
· Tu
· 1984
[cited by applicant]
US 4464167A
· Schoendorfer et al.
· 1984
[cited by applicant]
US 4466888A
· Verkaart
· 1984
[cited by applicant]
US 4482342A
· Lueptow et al.
· 1984
[cited by applicant]
US 4490135A
· Troutner
· 1984
[cited by applicant]
US 4530691A
· Brown
· 1985
[cited by applicant]
US 4534863A
· Bacon et al.
· 1985
[cited by applicant]
US 4643714A
· Brose
· 1987
[cited by applicant]
US 4647279A
· Mulzet et al.
· 1987
[cited by applicant]
US 4655742A
· Vantard
· 1987
[cited by applicant]
US 4680025A
· Kruger et al.
· 1987
[cited by applicant]
US 4684361A
· Feldman et al.
· 1987
[cited by applicant]
US 4692136A
· Feldman et al.
· 1987
[cited by applicant]
US 4708712A
· Mulzet
· 1987
[cited by applicant]
US 4713176A
· Schoendorfer et al.
· 1987
[cited by applicant]
US 4734089A
· Cullis
· 1988
[cited by applicant]
US 4740202A
· Stacey et al.
· 1988
[cited by applicant]
US 4740313A
· Schoendorfer et al.
· 1988
[cited by applicant]
US 4755300A
· Fischel et al.
· 1988
[cited by applicant]
US 4767396A
· Powers
· 1988
[cited by applicant]
US 4795419A
· Yawn et al.
· 1989
[cited by applicant]
US 4795448A
· Stacey et al.
· 1989
[cited by applicant]
US 4806247A
· Schoendorfer et al.
· 1989
[cited by applicant]
US 4806252A
· Brown et al.
· 1989
[cited by applicant]
US 4808307A
· Fischel et al.
· 1989
[cited by applicant]
US 4850995A
· Tie et al.
· 1989
[cited by applicant]
US 4869812A
· Schoendorfer et al.
· 1989
[cited by applicant]
US 4871462A
· Fischel et al.
· 1989
[cited by applicant]
US 4876013A
· Shmidt et al.
· 1989
[cited by applicant]
US 4889524A
· Fell et al.
· 1989
[cited by applicant]
US 4898675A
· Lavender
· 1990
[cited by applicant]
US 4911833A
· Schoendorfer et al.
· 1990
[cited by applicant]
US 4934995A
· Cullis
· 1990
[cited by applicant]
US 4940543A
· Brown et al.
· 1990
[cited by applicant]
US 4943273A
· Pages
· 1990
[cited by applicant]
US 4968295A
· Neumann
· 1990
[cited by applicant]
US 4980054A
· Lavender
· 1990
[cited by applicant]
US 4983156A
· Knelson
· 1991
[cited by applicant]
US 4983158A
· Headley
· 1991
[cited by applicant]
US 4985153A
· Kuroda et al.
· 1991
[cited by applicant]
US 4994188A
· Prince
· 1991
[cited by applicant]
US 5039401A
· Columbus et al.
· 1991
[cited by applicant]
US 5045048A
· Kaleskas et al.
· 1991
[cited by applicant]
US 5098372A
· Jonsson
· 1992
[cited by applicant]
US 5098373A
· Polaschegg
· 1992
[cited by applicant]
US 5100372A
· Headley
· 1992
[cited by applicant]
US 5100564A
· Pall et al.
· 1992
[cited by applicant]
US 5112298A
· Prince et al.
· 1992
[cited by applicant]
US 5114396A
· Unger et al.
· 1992
[cited by applicant]
US 5135667A
· Schoendorfer
· 1992
[cited by applicant]
US 5141486A
· Antwiler et al.
· 1992
[cited by applicant]
US 5147290A
· Jonsson
· 1992
[cited by applicant]
US 5154716A
· Bauman et al.
· 1992
[cited by applicant]
US 5174894A
· Ohsawa et al.
· 1992
[cited by applicant]
US 5178603A
· Prince
· 1993
[cited by applicant]
US 5194145A
· Schoendorfer
· 1993
[cited by applicant]
US 5217426A
· Bacehowski et al.
· 1993
[cited by applicant]
US 5217427A
· Cullis
· 1993
[cited by applicant]
US 5234403A
· Yoda et al.
· 1993
[cited by applicant]
US 5254248A
· Nakamura
· 1993
[cited by applicant]
US 5273517A
· Barone et al.
· 1993
[cited by applicant]
US 5277701A
· Christie et al.
· 1994
[cited by applicant]
US 5298016A
· Gordon
· 1994
[cited by applicant]
US 5298171A
· Biesel
· 1994
[cited by applicant]
US 5300060A
· Nelson
· 1994
[cited by applicant]
US 5316540A
· Mcmannis et al.
· 1994
[cited by applicant]
US 5318511A
· Riquier et al.
· 1994
[cited by applicant]
US 5318512A
· Neumann
· 1994
[cited by applicant]
US 5348533A
· Papillon et al.
· 1994
[cited by applicant]
US 5368542A
· Mcmannis et al.
· 1994
[cited by applicant]
US 5368555A
· Sussman et al.
· 1994
[cited by applicant]
US 5386734A
· Pusinelli
· 1995
[cited by applicant]
US 5387174A
· Rochat
· 1995
[cited by applicant]
US 5387187A
· Fell et al.
· 1995
[cited by applicant]
US 5403272A
· Deniega et al.
· 1995
[cited by applicant]
US 5405308A
· Headley et al.
· 1995
[cited by applicant]
US 5417650A
· Gordon
· 1995
[cited by applicant]
US 5431814A
· Jorgensen
· 1995
[cited by applicant]
US 5437598A
· Delbert
· 1995
[cited by applicant]
US 5437624A
· Langley
· 1995
[cited by applicant]
US 5462667A
· Wollinsky et al.
· 1995
[cited by applicant]
US 5470483A
· Bene et al.
· 1995
[cited by applicant]
US 5484396A
· Naficy
· 1996
[cited by applicant]
US 5494592A
· Latham et al.
· 1996
[cited by applicant]
US 5496265A
· Langley et al.
· 1996
[cited by applicant]
US 5505685A
· Delbert
· 1996
[cited by applicant]
US 5514070A
· Pages
· 1996
[cited by applicant]
US 5543062A
· Nishimura
· 1996
[cited by applicant]
US 5551941A
· Howell
· 1996
[cited by applicant]
US 5585007A
· Antanavich et al.
· 1996
[cited by applicant]
US 5607579A
· Latham et al.
· 1997
[cited by applicant]
US 5649903A
· Deniega et al.
· 1997
[cited by applicant]
US 5651766A
· Kingsley et al.
· 1997
[cited by applicant]
US 5656163A
· Brown
· 1997
[cited by applicant]
US 5665061A
· Antwiler
· 1997
[cited by applicant]
US 5681273A
· Brown
· 1997
[cited by applicant]
US 5686696A
· Baker, Jr. et al.
· 1997
[cited by applicant]
US 5712798A
· Langley et al.
· 1998
[cited by applicant]
US 5728060A
· Kingsley et al.
· 1998
[cited by applicant]
US 5733253A
· Headley et al.
· 1998
[cited by applicant]
US 5733446A
· Holm
· 1998
[cited by applicant]
US 5733545A
· Hood, III
· 1998
[cited by applicant]
US 5738792A
· Schoendorfer
· 1998
[cited by applicant]
US 5762791A
· Deniega et al.
· 1998
[cited by applicant]
US 5779660A
· Kingsley et al.
· 1998
[cited by applicant]
US 5783085A
· Fischel
· 1998
[cited by applicant]
US 5792351A
· Wehrle et al.
· 1998
[cited by applicant]
US 5849203A
· Brown et al.
· 1998
[cited by applicant]
US 5882289A
· Sakota et al.
· 1999
[cited by applicant]
US 5906589A
· Gordon et al.
· 1999
[cited by applicant]
US 5919125A
· Berch
· 1999
[cited by applicant]
US 5964724A
· Rivera et al.
· 1999
[cited by applicant]
US 5970432A
· Ishimoto et al.
· 1999
[cited by applicant]
US 5980760A
· Min et al.
· 1999
[cited by applicant]
US 6007725A
· Brown
· 1999
[cited by applicant]
US 6059979A
· Brown
· 2000
[cited by applicant]
US 6080322A
· Deniega et al.
· 2000
[cited by applicant]
US 6183651B1
· Brown et al.
· 2001
[cited by applicant]
US 6200287B1
· Keller et al.
· 2001
[cited by applicant]
US 6204694B1
· Sunter et al.
· 2001
[cited by applicant]
US 6207063B1
· Brown
· 2001
[cited by applicant]
US 6234989B1
· Brierton et al.
· 2001
[cited by applicant]
US 6251284B1
· Bischof et al.
· 2001
[cited by applicant]
US 6284142B1
· Muller
· 2001
[cited by applicant]
US 6287818B1
· Kazimir et al.
· 2001
[cited by applicant]
US 6296602B1
· Headley
· 2001
[cited by applicant]
US 6325775B1
· Thom et al.
· 2001
[cited by applicant]
US 6348156B1
· Vishnoi et al.
· 2002
[cited by applicant]
US 6405508B1
· Janesky
· 2002
[cited by applicant]
US 6464624B2
· Pages
· 2002
[cited by applicant]
US 6471855B1
· Odak
· 2002
[cited by applicant]
US 6497676B1
· Childers et al.
· 2002
[cited by applicant]
US 6558307B2
· Headley
· 2003
[cited by applicant]
US 6623443B1
· Polaschegg
· 2003
[cited by applicant]
US 6641552B1
· Kingsley et al.
· 2003
[cited by applicant]
US 6695806B2
· Gelfand et al.
· 2004
[cited by applicant]
US 6730054B2
· Pierce et al.
· 2004
[cited by applicant]
US 6730055B2
· Bainbridge et al.
· 2004
[cited by applicant]
US 6743192B1
· Sakota et al.
· 2004
[cited by applicant]
US 6746547B2
· Cole et al.
· 2004
[cited by applicant]
US 6983884B2
· Auchlinleck
· 2006
[cited by applicant]
US 7050611B2
· Bodicker et al.
· 2006
[cited by applicant]
US 7072769B2
· Fletcher-Haynes et al.
· 2006
[cited by applicant]
US 7115205B2
· Robinson et al.
· 2006
[cited by applicant]
US 7186231B2
· Takagi et al.
· 2007
[cited by applicant]
US 7270645B2
· Langley et al.
· 2007
[cited by applicant]
US 7282154B2
· Muller
· 2007
[cited by applicant]
US 7354415B2
· Bainbridge et al.
· 2008
[cited by applicant]
US 7476209B2
· Gara et al.
· 2009
[cited by applicant]
US 7704454B1
· Langley et al.
· 2010
[cited by applicant]
US 8204694B2
· Hauck et al.
· 2012
[cited by applicant]
US 8287818B2
· Kantrowitz et al.
· 2012
[cited by applicant]
US 8405508B2
· Burke
· 2013
[cited by applicant]
US 8628489B2
· Pages et al.
· 2014
[cited by applicant]
US 8702637B2
· Pages et al.
· 2014
[cited by applicant]
US 8746547B2
· Mollstam et al.
· 2014
[cited by applicant]
US 8759094B2
· Ranby et al.
· 2014
[cited by applicant]
US 8840790B2
· Wegener et al.
· 2014
[cited by applicant]
US 9011359B2
· Wegener et al.
· 2015
[cited by applicant]
US 9095665B2
· Pagès et al.
· 2015
[cited by applicant]
US 9283316B2
· Flexman
· 2016
[cited by applicant]
US 9302042B2
· Pages et al.
· 2016
[cited by applicant]
US 9364600B2
· Pagès et al.
· 2016
[cited by applicant]
US 9393359B2
· Boggs et al.
· 2016
[cited by applicant]
US 20010000018A1
· Truong et al.
· 2001
[cited by applicant]
US 20010027156A1
· Egozy et al.
· 2001
[cited by applicant]
US 20020043492A1
· Bischof
· 2002
[cited by applicant]
US 20020062100A1
· Pierce et al.
· 2002
[cited by applicant]
US 20020120227A1
· Childers et al.
· 2002
[cited by applicant]
US 20020151804A1
· O'mahony et al.
· 2002
[cited by applicant]
US 20030066807A1
· Suzuki
· 2003
[cited by applicant]
US 20030125881A1
· Ryan
· 2003
[cited by applicant]
US 20030140928A1
· Bui et al.
· 2003
[cited by applicant]
US 20040183683A1
· Funahashi
· 2004
[cited by applicant]
US 20040199098A1
· Pierce et al.
· 2004
[cited by applicant]
US 20050228238A1
· Monitzer
· 2005
[cited by applicant]
US 20060058167A1
· Ragusa et al.
· 2006
[cited by applicant]
US 20060226086A1
· Robinson et al.
· 2006
[cited by applicant]
US 20120010062A1
· Fletcher et al.
· 2012
[cited by applicant]
US 20150367063A1
· Kimura
· 2015
[cited by applicant]
CN 2735985Y
· 2005
[cited by applicant]
CN 102046223A
· 2011
[cited by applicant]
CN 102395392A
· 2012
[cited by applicant]
CN 104800905A
· 2015
[cited by applicant]
CN 204446748U
· 2015
[cited by applicant]
EP 0128683A2
· 1984
[cited by applicant]
EP 0171749A1
· 1986
[cited by applicant]
EP 0208061A1
· 1987
[cited by applicant]
EP 0229504A2
· 1987
[cited by applicant]
EP 0257755A1
· 1988
[cited by applicant]
EP 0350162A1
· 1990
[cited by applicant]
EP 0578086A1
· 1994
[cited by applicant]
EP 0619145A2
· 1994
[cited by applicant]
EP 0654277A1
· 1995
[cited by applicant]
EP 0664159A1
· 1995
[cited by applicant]
EP 0799645A1
· 1997
[cited by applicant]
EP 0885619A1
· 1998
[cited by applicant]
EP 1057534A1
· 2000
[cited by applicant]
EP 1295619A2
· 2003
[cited by applicant]
EP 1374927A1
· 2004
[cited by applicant]
EP 2650030A1
· 2013
[cited by applicant]
FR 2258898A1
· 1977
[cited by applicant]
JP S596952A
· 1984
[cited by applicant]
JP S5969166A
· 1984
[cited by applicant]
JP H0252665A
· 1990
[cited by applicant]
JP H03131268A
· 1991
[cited by applicant]
JP H0775746A
· 1995
[cited by applicant]
JP H08131539A
· 1996
[cited by applicant]
JP H09192215A
· 1997
[cited by applicant]
JP 2002282352A
· 2002
[cited by applicant]
JP 2002291872A
· 2002
[cited by applicant]
JP 3936132B
· 2007
[cited by applicant]
JP 2008506424A
· 2008
[cited by applicant]
RU 2252788C1
· 2005
[cited by applicant]
SU 660718A1
· 1979
[cited by applicant]
SU 762982A1
· 1980
[cited by applicant]
SU 1146098A1
· 1985
[cited by applicant]
WO 8502561A1
· 1985
[cited by applicant]
WO 9000059A1
· 1990
[cited by applicant]
WO 9007383A1
· 1990
[cited by applicant]
WO 9406535A1
· 1994
[cited by applicant]
WO 9611747A2
· 1996
[cited by applicant]
WO 9633023A1
· 1996
[cited by applicant]
WO 0205059A2
· 2002
[cited by applicant]
WO 2007041716A1
· 2007
[cited by applicant]
WO 2017053055A1
· 2017
[cited by applicant]
WO 2018222441A1
· 2018
[cited by applicant]
WO 2019084278A1
· 2019
[cited by applicant]
Altunatas, F., et al., Comparison of Plateletpheresis on the Fenwal Amicus and Fresenius Com. Tec Cell Separators, Transfusion Medicine and Hemotherapy, vol. 35, pp. 368-373, 2008.
[cited by applicant]
Amendment and Argument filed Dec. 15, 2021 in Japanese Application No. 2020202093 with English translation (12 pages).
[cited by applicant]
Amendment and Argument filed on Aug. 6, 2021 in Korean Application No. 10-2020-7033247 with English translation (11 pages.).
[cited by applicant]
Amendment and Reply in U.S. Appl. No. 16/739,441 dated Apr. 5, 2022, 13 pages.
[cited by applicant]
Amendment filed in U.S. Appl. No. 17/306,099, dated Nov. 2, 2021, 17 pages.
[cited by applicant]
Amendment in U.S. Appl. No. 17/306,099 dated Apr. 5, 2022, 18 pages.
[cited by applicant]
Amendment to the application with English translation for Korean Patent Application No. 10-2020-7033175 dated May 24, 2021 (11 pages).
[cited by applicant]
Anonymous, 21 CFR Parts 606, 610, 630, et l.; Requirements for Blood and Blood Components Intended for Transfusion or for Further Manufacturing Use; Final Rule, Federal Register. vol. 80, 2015.
[cited by applicant]
Anonymous, Code of Federal Regulations, §606.110 General donor eligibility requirements, Code of Federal Regulations, National Archives, May 2020.
[cited by applicant]
Anonymous, Code of Federal Regulations, §630.10 General donor eligibility requirements, Code of Federal Regulations, National Archives, May 2020.
[cited by applicant]
Anonymous, Code of Federal Regulations, §630.15 Donor eligibility requirements, Code of Federal Regulations, National Archives, May 2020.
[cited by applicant]
Anonymous, Code of Federal Regulations, §640.65 Plasmapheresis, Code of Federal Regulations, National Archives, pp. 105-107, Apr. 2020.
[cited by applicant]
Applicant-Initiated Interview Summary, U.S. Appl. No. 17/306,099, dated Nov. 5, 2021, 17 pages.
[cited by applicant]
Argument in Response to Notice of Preliminary Rejection in Korean Application No. 10-2020-7031496 dated Nov. 10, 2022.
[cited by applicant]
Bialkowski W., et al., Citrate anticoagulation: Are blood donors donating bone?, Journal of clinical apheresis, United States, vol. 31, pp. 459-463, Oct. 2016.
[cited by applicant]
Bird et al., “New gender-specific formulae for estimating extracellular fluid vol. from height and weight in adults,” Nuclear Medicine Communications. vol. 42. No. 1. Oct. 9, 2020, (Oct. 9, 2020), 2 pages.
[cited by applicant]
Blaha, M. et al., Experience with extracorporeal elimination therapy in myasthenia gravis, Transfusion and Apheresis Science Elsevier Science, London, GB, vol. 45, pp. 252-256, 2011.
[cited by applicant]
Body fluid compartments of a 70-kg adult man, PhysiologyWeb [online], Nov. 2, 2015—4-5, 16-18 (Nov. 14, 2015), Retrieved from the Internet (2 pages).
[cited by applicant]
Burgstaler, E. A., Blood component collection by apheresis, Journal of clinical apheresis, United States, Journal 01 clinical apheresis, United States, vol. 21, pp. 142-151, Jul. 2006.
[cited by applicant]
Burgstaler, E.A., et al., Paired comparison of therapeutic plasma exchange using the Fenwal Amicus versus TerumoBCT Spectra Optia, Journal of clinical apheresis, United States, vol. 33, pp. 265-273, Jun. 2018.
[cited by applicant]
Canadian Office Action for Canadian Application No. 3099428, dated Nov. 14, 2022, 5 pages.
[cited by applicant]
Canadian Requisition in Accordance with Subsection 86(2) of the Patent Rules dated Sep. 28, 2021 for Canadian Application No. 3,899,420.
[cited by applicant]
Caridian BCT; Operator's Manual: Trima Accel® Automated Blood Collection System for Version 6.0 with Automated RBC Processes; Part No. 777095-197, Jun. 2010, (296 pages).
[cited by applicant]
Charifa, A. et al., Transfusion medicine equations made internet accessible, American Journal of Clinical Pathology 20181001, Oxford University Press, vol. 150, Oct. 2018.
[cited by applicant]
China National Intellectual Property Administration Notification of the First Office Action dated Dec. 6, 2021 for Chinese International Application No. 201980031598.1.
[cited by applicant]
Colpo, A., et al., Therapeutic apheresis during pregnancy: A single center experience, Transfusion And Apheresis Science, Elsevier Science, London, GB, Sep. 5, 2019.
[cited by applicant]
Communication pursuant to Article 94(3) EPC, Application No. 21198088.3, dated Jun. 13, 2022, 6 pages.
[cited by applicant]
Compliance Program Guidance Manual, Chapter 42—Blood and Blood Components, Inspection of Source Plasma Establishments, Brokers, Testing Laboratories, and Contractors—7342.002, Completion Date: Jan. 31, 2019, (63 pages).
[cited by applicant]
Cordts, P.R. et al., Poor predictive value of hematocrit and hemodynamic parameters for erythrocyte deficits after extensive elective vascular operations, Surgery, gynecology & obstetrics, United States, vol. 175, pp. 2…
[cited by applicant]
De Back, D. Z. et al., Therapeutic plasma apheresis: Expertise and indications, Transfusion and Apheresis Science, vol. 58, pp. 254-257, Jun. 2019.
[cited by applicant]
Director, Center for Biologics Evaluation and Research, Volume Limits for Automated Collection of Source Plasma, Nov. 4, 1992 (3 pages).
[cited by applicant]
Evers, J. et al., Distribution of citrate and citrate infusion rate during donor plasmaphereses, Journal of clinical apheresis, United States, vol. 31, pp. 59-62, Feb. 2016.
[cited by applicant]
Examination Report in AU 2021204735 (dated Aug. 18, 2022).
[cited by applicant]
Examination report No. 1 for standard patent application for Australian patent No. 2019274489 dated Nov. 16, 2020 (4 pages).
[cited by applicant]
Examination report No. 1 for standard patent application for Australian patent No. 2020267188 dated Nov. 25, 2020 (7 pages).
[cited by applicant]
Examiner Requisition in Canada App. 3,099,428 dated Mar. 28, 2022, 4 pages.
[cited by applicant]
Extended EP Search Report in EP Application No. 21198088 (dated Nov. 10, 2021).
[cited by applicant]
Extended European Search Report dated Nov. 8, 2021 for European Application No. 21183088.0.
[cited by applicant]
Extended European Search Report, counterpart EP Application No. 21168049.1 (Aug. 17, 2021) (8 pages).
[cited by applicant]
Extended European Search Report, counterpart EP Application No. 21168049.1 (dated Aug. 17, 2021) (8 pages).
[cited by applicant]
Feldschuh, J. et al., Prediction of the Normal Blood Volume Relation of Blood Volume To Body Habitus, Circulation 1977, vol. 56, pp. 605-612, Oct. 1977.
[cited by applicant]
Feldschuh, J. et al., The importance of correct norms in blood volume measurement, The American journal of the medical sciences, United States, vol. 334, pp. 41-46, Jul. 2007.
[cited by applicant]
Fenwal: AmicusTM Separator: Operator's Manual SW v. 4.3; Ref 4R4580, 4R4580R, Jun. 2011, (501 pages).
[cited by applicant]
Fenwal: AmicusTM Separator: Therapeutics Supplement Manual SW v. 4.2, Mononuclear Cell Collection + Therapeutic Plasma Exchange; Ref 4R4580, 4R4580R, Apr. 2011, (372 pages).
[cited by applicant]
Fenwal: AmicusTM Separator: Therapeutics Supplement Manual SW v. 4.3, Mononuclear Cell Collection + Therapeutic Plasma Exchange; Ref 4R4580, 4R4580R, Mar. 2012, 372 pages.
[cited by applicant]
First Examination Report in Saudi Arabia patent application 520420610 based on PCT/WO/US2019/033318 (11 pages) and partial translation thereof (2 pages).
[cited by applicant]
Fresenius Kabi: Amicus Separator: Operator's Manual SW v. 5.1, vol. 2—Platelets with Concurrent Plasma or RBC Collection, Ref 4R4580, 4R4580R, 4R4580TH, 6R4580, GR4580R, Mar. 2017, 352 pages.
[cited by applicant]
Gokay, S. et al., Long-term efficacy of lipoprotein apheresis in the management of familial hypercholesterolaemia: 37 Application of two different apheresis techniques in childhood, Transfusion And Apheresis Science, El…
[cited by applicant]
Hadem, J. et al., Therapeutic plasma exchange as rescue therapy in severe sepsis and septic shock: retrospective 33 observational single-centre study of 23 patients, BMC Anesthesiology, Biomed Central, London, GB, vol. …
[cited by applicant]
Hafer, C. et al., Membrane versus centrifuge-based therapeutic plasma exchange: a randomized prospective 38 crossover study, International urology and Nephrology, Akademiai, Budapest, HU, vol. 48, pp. 133-138, 2016.
[cited by applicant]
Hafer, C. et al., Pro: High dose of therapeutic plasma exchange-mind the gap!, Nephrology, dialysis, transplantation: 40 official publication of the European Dialysis and Transplant Association—European Renal Associatio…
[cited by applicant]
Hattersley, J.G. et al., Describing the effectiveness of immunosuppression drugs and apheresis in the treatment of 30 transplant patients, Computer Methods And Programs In Biomedicine, Amsterdam, NL, vol. 109, pp. 126-1…
[cited by applicant]
Hauser, R. G. et al., Transfusion Medicine Equations Made Internet Accessible, Transfusion Medicine Reviews, vol. 34, 2020.
[cited by applicant]
International Search Report (17 pages) and Notification (2 pages) in International app No. PCT/US22/27484 dated May 3, 2022.
[cited by applicant]
International Search Report and Written Opinion dated Dec. 1, 2021 for International Application No. PCT/US2021/047124.
[cited by applicant]
International Search Report and Written Opinion dated Sep. 30, 2021 for International Application No. PCT/JS21/33835.
[cited by applicant]
International Search Report and Written Opinion for Application No. PCT/US2018/033826, dated Aug. 3, 2018, 10 pages.
[cited by applicant]
International Search Report and Written Opinion for Application No. PCT/US2018/57528, dated Jan. 7, 2019, 17 pages.
[cited by applicant]
International Search Report and Written Opinion for International Application No. PCT/US22/27484 dated May 3, 2022, 15 pages.
[cited by applicant]
International Search Report and Written Opinion, counterpart International App. No. PCT/US2021/033835 (dated Sep. 30, 2021) (20 pages).
[cited by applicant]
International Search Report and Written Opinion, counterpart International Appl. No. PCT/US2019/033318 (dated Aug. 21, 2019) (14 pages).
[cited by applicant]
International Search Report and Written Opinion, counterpart International Application No. PCT/US2019/033318 dated Aug. 21, 2019, 14 pages.
[cited by applicant]
Jia, Z.S. et al., Total blood volume of Asian patients undergoing cardiac surgery is far from that predicted by conventional methods, The Journal of cardiovascular surgery, Italy, vol. 54, pp. 423-430, Jun. 2013.
[cited by applicant]
Kawai, Y. et al., Therapeutic plasma exchange may improve hemodynamics and organ failure among children with sepsis-induced multiple organ dysfunction syndrome receiving extracorporeal life support, Pediatric critical c…
[cited by applicant]
Keklik, M. et al., Effectiveness of the haemonetics MCS cell separator in the collection of apheresis platelets, Transfusion and Apheresis Science Elsevier Science, London, GB, vol. 53, pp. 396-398, Aug. 2015.
[cited by applicant]
Kochinke, F. et al., Modelling of LDL-apheresis: System efficacy and rebound kinetics, Plasma Therapy and Transfusion Technology, vol. 9, pp. 35-44, 1988.
[cited by applicant]
Kuan, Jew-Win et al., A randomized double blind control trial comparing filgrastim and pegfilgrastim in cyclophosphamide peripheral blood hematopoietic stem cell mobilization, Transfusion and Apheresis Science Elsevier …
[cited by applicant]
Kubeček, O. et al., Plasmafiltration as an effective method in the removal of circulating pegylated liposomal doxorubicin (PLD) and the reduction of mucocutaneous toxicity during the treatment of advanced platinum-resis…
[cited by applicant]
Lambert, C. et al., Plasma extraction rate and collection efficiency during therapeutic plasma exchange with Spectra Optia in comparison with Haemonetics MCS+, Journal of clinical apheresis, United States, vol. 26, pp. …
[cited by applicant]
Lemmens, H. et al., Estimating Blood Volume in Obese and Morbidly Obese Patients, Obesity Surgery, vol. 16, pp. 773-776, 2006.
[cited by applicant]
Lin, Shi-Woei et al., Optimal collecting policy for apheresis platelets in a regional blood center, Vox Sanguinis, vol. 115, pp. 148-158, 2020.
[cited by applicant]
Linderkamp, O. et al., Estimation and Prediction of Blood Volume in Infants and Children, European Journal of Pediatrics, vol. 125, pp. 227-234, Aug. 1977.
[cited by applicant]
Lopez, A.J., et al., Monitoring and isolation of blood dendritic cells from apheresis products in healthy individuals: a platform for cancer immunotherapy, Journal of Immunological Methods, Sep. 15, 2002 Elsevier Scienc…
[cited by applicant]
Maikowski & Ninnemann letter in European application 21168049.1, dated Mar. 29, 2022.
[cited by applicant]
Maitta, Robert W., Current state of apheresis technology and its applications, Transfusion and Apheresis Science, vol. 57, pp. 606-613, Oct. 2018.
[cited by applicant]
Merolle, L., et al., The effect of donor's characteristics on plasmapheresis products: insights for a personalized approach, Blood transfusion=Trasfusione del sangue, Italy, May 2020.
[cited by applicant]
Miladi, M.I. et al., Relevance of palsma exchange in the treatment of Myasthenia gravis: Study of 11 cases, Revue de Medecine Interne, vol. 29, pp. 87-93, 2008.
[cited by applicant]
Neff, L.P., The use of therapeutic plasma exchange (TPE) in the setting of refractory burn shock, Burns 2010 Elsevier Ltd., vol. 36, pp. 372-378, 2010.
[cited by applicant]
Neyrinck, M.M. et al., Calculations in apheresis, Journal of clinical apheresis, vol. 30, pp. 38-42, Feb. 2015.
[cited by applicant]
Notice for Reasons for Refusal in Japan App. 2020-202093 dated Jan. 11, 2022, 3 pages.
[cited by applicant]
Notice of Allowance in U.S. Appl. No. 17/386,992 dated Feb. 9, 2022, 8 pages.
[cited by applicant]
Notice of Preliminary Rejection with English translation for Korean Patent Application No. 10-2020-7033247 dated Mar. 22, 2021 (31 pages).
[cited by applicant]
Notice of Preliminary Rejection with English translation for Korean Patent No. 10-2020-7033175 dated Mar. 22, 2021 (13 pages).
[cited by applicant]
Notice of Reasons for Refusal in Japan Application 2020-202093 dated Jan. 11, 2022, 3 pages.
[cited by applicant]
Notice of Reasons of Refusal with English translation, counterpart Japanese application 2020-202093 dated Jun. 15, 2021 (8 pages).
[cited by applicant]
Notice of Reasons of Refusal with English translation, counterpart Japanese application 2020-202093 dated Jun. 15, 2021.
[cited by applicant]
Notice of Reasons of Refusal with English translation, counterpart Japanese application 2020-557304 dated May 11, 2021 (8 pages).
[cited by applicant]
Notice of Refusal in Japanese Patent Application No. 2022-104191 dated May 26, 2023.
[cited by applicant]
Office Action in Canadian Patent Application 3,099,428 (dated Mar. 28, 2022).
[cited by applicant]
Office Action in Russia Application 2021120042 (dated Feb. 28, 2022).
[cited by applicant]
Office communication in U.S. Appl. No. 17/078,824 dated Nov. 3, 2021, 22 pages.
[cited by applicant]
Office communication in U.S. Appl. No. 17/306,099 dated Dec. 6, 2021, 17 pages.
[cited by applicant]
Office communication in U.S. Appl. No. 17/306,099 dated Sep. 23, 2021, 19 pages.
[cited by applicant]
Partial Translation of Second Examination Report in Saudi Arabia Application 520420610, dated Jun. 11, 2023.
[cited by applicant]
PCT/US21/33835, filed May 24, 2021.
[cited by applicant]
PCT/US21/47124, filed Aug. 23, 2021.
[cited by applicant]
PCT/US22/27484, filed May 31, 2022.
[cited by applicant]